CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing advanced imaging methods to detect changes in cancer signaling pathways using hybrid Positron Emission Tomography/Magnetic Resonance Imaging technology. It aims to enhance the understanding of cancer progression and improve personalized treatment strategies.
Spatial and temporal changes in the underlying biochemistry of cancer control disease progression and response/resistance to treatment.
Developing methods to detect changes in oncogenic signaling at an early stage is vital to further our understanding of cancer, and will advance the next generation of anti-cancer therapies.
Nanomedicine is the medical application of nanotechnology to diagnose or treat disease.
In light of the recent introduction of tools like Positron Emission Tomography/Magneti…
UNIVERSITAT ZURICH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
